Evidence map›Paper›PMID 32711466›Full record

Observational studyBMC nephrology2020

Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.

Hyo Jin Yun, Soo Ryeong Ryoo, Jung-Eun Kim, Yong Jun Choi, Inwhee Park, Gyu-Tae Shin, Heungsoo Kim, Jong Cheol Jeong

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Update on trabecular bone score.Archives of endocrinology and metabolism · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hyo Jin YunDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Soo Ryeong RyooDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Jung-Eun KimDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Yong Jun ChoiDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
Inwhee ParkDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Gyu-Tae ShinDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Heungsoo KimDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea.
Jong Cheol JeongDepartment of Nephrology, Ajou University School of Medicine, Suwon, South Korea. jcj0425@empal.com.ORCID 0000-0003-0301-7644
Ajou University · KRSeoul National University Bundang Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the general population, the trabecular bone score (TBS) represents the bone microarchitecture and predicts fracture risk independent of bone mineral density (BMD). A few studies reported that TBS is significantly reduced in dialysis patients. Chronic kidney disease-mineral and bone disorder (CKD-MBD) are accompanied by increased fracture risk, cardiovascular morbidity, and mortality. We investigated whether TBS is associated with comorbidity related to CKD-MBD or frailty in hemodialysis patients.

methodsIn this prospective observational study, TBS was obtained using the TBS iNsight software program (Med-Imaps) with BMD dual energy x-ray absorptiometry (DXA) images (L1-L4) from prevalent hemodialysis patients. A Tilburg frailty indicator was used to evaluate frailty, and hand grip strength and bio-impedance (InBody) were measured. A patient-generated subjective global assessment (PG-SGA) was used for nutritional assessment. The history of cardiovascular events (CVE) and demographic, clinical, laboratory, and biomarker data were collated. We then followed up patients for the occurrence of CKD-MBD related complications.

resultsWe enrolled 57 patients in total. The mean age was 56.8 ± 15.9 years (50.9% female). Prevalence of Diabetes mellitus (DM) was 40.4% and CVE was 36.8%. Mean TBS was 1.44 ± 0.10. TBS significantly reduced in the CVE group (1.38 ± 0.08 vs. 1.48 ± 0.10, p <  0.001). Multivariable regression analysis was conducted adjusting for age, sex, dialysis vintage, DM, CVE, albumin, intact parathyroid hormone, fibroblast growth factor 23, handgrip strength, and phosphate binder dose. Age (ß = - 0.030; p = 0.001) and CVE (ß = - 0.055; p = 0.024) were significant predictors of TBS. During the follow up period after TBS measurements (about 20 months), four deaths, seven incident fractures, and six new onset CVE were recorded. Lower TBS was associated with mortality (p = 0.049) or new onset fracture (p = 0.007, by log-rank test).

conclusionLower TBS was independently associated with increased age and CVE prevalence in hemodialysis patients. Mortality and fracture incidence were significantly higher in patients with lower TBS values. These findings suggest that TBS may indicate a phenotype of frailty and also a CKD-MBD phenotype reciprocal to CVE.

Indexed as

Absorptiometry, PhotonAdultAgedBone DensityCancellous BoneCardiovascular DiseasesChronic Kidney Disease-Mineral and Bone DisorderDiabetes MellitusFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsFractures, BoneHand StrengthHumansKidney Failure, ChronicMaleFibroblast Growth Factor-23Fibroblast Growth FactorsParathyroid HormoneSerum AlbuminCardiovascular eventsChronic kidney disease-mineral and bone disorderEnd stage renal diseaseFractureHemodialysisMortalityTrabecular bone score

Identifiers

PMID32711466
PMCPMC7382149
OpenAlexW3044710189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.